Ceragenix Pharmaceuticals - Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
dBusinessNews.com - DENVER -- Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC) Ceragenix Pharmaceuticals, Inc. a biopharmaceutical company focused on infectious disease and dermatology, today announced that the American Society of Microbiology
Ceragenix Pharmaceuticals, Inc. CEO Featured in Exclusive
MSN MoneyCentral - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. (OTC Bulletin Board: CGXP) updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview
Colorado business, 7/27
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical
Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on
0 Comments:
Post a Comment
<< Ceragenix Pharmaceuticals: Ceragenix Pharmaceuticals - Research on Use of Ceragenins(TM) As Potential Therapy for Cystic Home Page